October babies are more likely to develop the syndrome, according to a study presented at the Congress of the European Academy of Neurology (Amsterdam, The Netherlands).
Browsing: neuromuscular disease
Researchers demonstrate that amyotrophic lateral sclerosis (ALS) neuronal degeneration may be reduced following treatment with a growth factor, IGF-2, indicating a possible new target for ALS treatment.
This editorial article discusses a potential contribution of gut defects in the course of amyotrophic lateral sclerosis.
A study monitoring the brain activity of two patients with amyotrophic lateral sclerosis provides insight into how neurons control muscle movement in humans.